Dr Casillas-Espinosa was trained as a medical doctor (MD) at the University of Guadalajara, Mexico, before moving to Australia to study his PhD with Prof Terence O'Brien at the University of Melbourne.

Dr Casillas-Espinosa is a Lab Head of the neuroscience department at Monash University and a NHMRC Early Career Fellow. He has an impressive track record at this stage of his career with multiple publications and international presentations, many of which relate to the preclinical development of new epilepsy therapies and chronic animal models. He is an emerging leader in the field of epilepsy, biomarkers and drug development within just four years of the completion of my PhD (Top 0.50% Worldwide Epilepsy Experts, expertscape.com). His Lab group focuses on finding novel disease-modifying treatments and targets of brain diseases using multi-omics and computational approaches. Dr Casillas-Espinosa's group uses a wide range of models of epilepsy, stroke and traumatic brain injury, from molecular and cellular assays of neuropathology to neurobehavioural assessments and advanced neuroimaging techniques (MRI, DTI, PET).   I have successfully obtained competitive grants, resulting in high-impact publications and one patent (PCT/US2017/000097), and ongoing clinical trials of novel therapies. Dr Casillas-Espinosa has a growing international reputation, evidenced by his increasing number of international competitive prizes, awards, and invited talks. CI Casillas-Espinosa is involved in invitation-only committees of the International League Against Epilepsy (ILAE). He is the Global Secretary of the Young Epilepsy Section of the ILAE.